Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration

Alja Zottel(University of Ljubljana), Radovan Komel(University of Ljubljana), Jernej Šribar(Jožef Stefan Institute), Neja Šamec(University of Ljubljana), Marija Skoblar Vidmar(Institute of Oncology Ljubljana), Jernej Mlakar(University of Ljubljana), Ivana Jovčevska(University of Ljubljana), Igor Križaj(Jožef Stefan Institute)
Therapeutic Advances in Medical Oncology
January 1, 2020
Cited by 41


Related Papers